John Mozas is an experienced leader in the healthcare and business sectors, currently serving as a Board Member for Midland Appliance and King's Pastry, as well as a Strategic Advisor for Creyos and Altum Health - University Health Network. Mozas' career includes notable positions such as CEO of Akira Health, where the company was co-founded under his leadership in 2016, and President and CEO of Medcan Clinic, where growth was achieved from 30 to 350 employees and established Medcan as North America's largest executive health provider. Before that, Mozas held key roles at Grocery Gateway, where significant revenue growth occurred, and at GlaxoSmithKline, overseeing the integration and market access of products. Educational qualifications include an M.B.A. from the Schulich School of Business and a B.Com. from the University of Toronto.
This person is not in any teams
This person is not in any offices
Creyos (formerly Cambridge Brain Sciences)
1 followers
Creyos (formerly Cambridge Brain Sciences) is a leading web-based platform for the assessment of brain health. It allows you to obtain accurate, quantified and scientifically-validated measures of key aspects of cognition, including short-term memory, attention, reasoning, and verbal ability. Creyos offers two core products – Creyos Health and Creyos Research. Built for health care practitioners, Creyos Health is an online brain health assessment service that takes seconds to set up, is engaging and enjoyable for patients, and produces a reliable and scientifically-validated cognitive assessment report in as little as 15 minutes. It is used by leading health care clinics around the world to track brain health over time as part of cognitive treatment and wellness plans. Healthcare providers using Creyos Health also have access to digital versions of many standardized patient health questionnaires. Creyos Research is made for researchers running studies on cognition in academic and commercial settings, allowing for the collection of cognitive data at scale. It has been used by many leading institutions, including Baycrest, Pfizer and Roche. Both products allow for assessment customization and online administration, require no expert technical support to administer and enable you to store and manage cognitive data securely in the cloud. Creyos maintains a global normative database of more than 85,000 participants (built off of our larger database of 12+ million completed cognitive tasks) that enables you to derive detailed comparisons of individuals to specific populations. The Cambridge Brain Sciences (now Creyos) cognitive tasks were developed in the laboratory of Dr. Adrian Owen, Canada Excellence Research Chair in Cognitive Neuroscience and Imaging (owenlab.org), over the course of his 25-year career. Over 300 scientific studies have been run to date using our tests, yielding numerous publications in leading academic journals.
Employees
51-200